Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, AFT Pharmaceuticals's Enterprise Value is NZ$428.6 Mil.
AFT Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$24.1 Mil. Therefore, AFT Pharmaceuticals's EV-to-EBIT ratio for today is 17.79.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, AFT Pharmaceuticals's Enterprise Value is NZ$428.6 Mil.
AFT Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$27.8 Mil. Therefore, AFT Pharmaceuticals's EV-to-EBITDA ratio for today is 15.42.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, AFT Pharmaceuticals's Enterprise Value is NZ$428.6 Mil.
AFT Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$251.2 Mil. Therefore, AFT Pharmaceuticals's EV-to-Revenue ratio for today is 1.71.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
AFT Pharmaceuticals (NZSE:AFT) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
AFT Pharmaceuticals's current Enterprise Value is NZ$428.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. AFT Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$24.1 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
AFT Pharmaceuticals's current Enterprise Value is NZ$428.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. AFT Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$27.8 Mil.
AFT Pharmaceuticals's current Enterprise Value is NZ$428.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. AFT Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$251.2 Mil.
AFT Pharmaceuticals's current Enterprise Value is NZ$428.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. AFT Pharmaceuticals's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$-9.5 Mil.
AFT Pharmaceuticals's current Enterprise Value is NZ$428.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. AFT Pharmaceuticals's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$-19.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AFT Pharmaceuticals Enterprise Value Related Terms
AFT Pharmaceuticals Enterprise Value Historical Data
* Premium members only.
The historical data trend for AFT Pharmaceuticals's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NZSE:AFT vs ZTS, UTHR, VTRS: Enterprise Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, AFT Pharmaceuticals's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AFT Pharmaceuticals Enterprise Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, AFT Pharmaceuticals's Enterprise Value distribution charts can be found below:
* The bar in red indicates where AFT Pharmaceuticals's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
AFT Pharmaceuticals's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of NZ$428.6 Mil mean?
AFT Pharmaceuticals (NZSE:AFT) has a Enterprise Value of NZ$428.6 Mil as of Jun. 29, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on AFT Pharmaceuticals and its competitors.
Is AFT Pharmaceuticals' Enterprise Value too high?
AFT Pharmaceuticals' current Enterprise Value is NZ$428.6 Mil. Overall, AFT Pharmaceuticals has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does AFT Pharmaceuticals' Enterprise Value compare to ZTS and UTHR?
AFT Pharmaceuticals' Enterprise Value of NZ$428.6 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on AFT Pharmaceuticals and its competitors. AFT Pharmaceuticals's current Enterprise Value is NZ$428.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AFT Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, AFT Pharmaceuticals (NZSE:AFT) is currently considered Modestly Undervalued. The stock's GF Value™ is NZ$4.15, compared to a current price of NZ$3.70 — trading 10.8% below its estimated fair value. The current Enterprise Value is NZ$428.6 Mil. AFT Pharmaceuticals' overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For AFT Pharmaceuticals (NZSE:AFT), the current Enterprise Value is NZ$428.6 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AFT Pharmaceuticals (NZSE:AFT) Overvalued in 2026?
Based on GuruFocus' analysis, AFT Pharmaceuticals stock appears to be undervalued.
The current stock price of NZ$3.70 is trading 10.8% below its estimated GF Value™ of NZ$4.15.
GuruFocus considers AFT Pharmaceuticals to be Modestly Undervalued.
Key valuation signals for NZSE:AFT:
Enterprise Value: NZ$428.6 Mil
GF Value™: NZ$4.15 vs. price of NZ$3.70 (10.8% below fair value)
No single metric tells the full story. See the NZSE:AFT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Maxigesic dose forms, Capsaicin creams, Crystaderm, Kiwisoothe, Micolette, and others. The group has four operating segments based on geographical location being Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia, which includes the sales and distribution activity relating to the Australian market.
96GF Score
Get the complete analysis for NZSE:AFT
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:AFT has been successfully added to your 
